【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Overview of cancer immunotherapies
• Epidemiology
• Spending on cancer
• Cost of cancer treatment
• Reimbursement policies
• Economic burden of cancer
• Orphan drug designation and regulatory approvals
PART 06: Pipeline portfolio
• Anticipated number of products with single and multi-indications by 2020
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by type
• Cancer monoclonal antibodies
• Clinical trials of cancer monoclonal antibodies
• Immune checkpoint inhibitors
• Cancer vaccines
• Non-specific immunotherapies
• Global cancer monoclonal antibodies market
• Global cancer vaccines market
• Global immune checkpoint inhibitors market
• Global non-specific immunotherapies market
PART 09: Geographical segmentation
• Global cancer immunotherapies market by geography 2015-2020
• Cancer immunotherapies market in Americas
• Cancer immunotherapies market in EMEA
• Cancer immunotherapies market in APAC
PART 10: Market drivers
• Increase in prevalence of cancers
• Increase in demand for cancer monoclonal antibodies
• Patient assistance programs
• Promising pipeline
PART 11: Impact of drivers
PART 12: Market challenges
• Patent expiry of top-selling drugs
• Poor diagnosis and screening
• High developmental costs
• Risk of side-effects
• Stringent regulations
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Increase in cancer awareness
• Emergence of targeted and combination therapies
• Emergence of biosimilars
• Strategic alliances
PART 15: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Amgen
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Merck
• Takeda Pharmaceuticals1
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Cancer immunotherapies in global cancer drugs market
Exhibit 03: Global incidence of cancer by type 2015
Exhibit 04: Global mortality by cancer type 2015
Exhibit 05: Estimated numbers of male and female cancer survivors by age in US 2014
Exhibit 06: Spending on cancer by distribution channels 2013
Exhibit 07: Annual treatment cost per patient for cancer immunotherapies 2014
Exhibit 08: Average cost of surgeries associated with cancer ($ millions) 2014
Exhibit 09: National reimbursement of cancer drugs by countries 2014
Exhibit 10: US FDA Orphan drug designations and approvals for cancer immunotherapies
Exhibit 11: EU orphan drug designations and approvals for cancer immunotherapies
Exhibit 12: Key events in cancer immunotherapies, discovery, and approvals
Exhibit 13: Timeline of some cancer immunotherapies
Exhibit 14: Phase III pipeline molecules for global cancer monoclonal antibodies market
Exhibit 15: Phase II pipeline molecules for global cancer monoclonal antibodies market
Exhibit 16: Phase I pipeline molecules for global cancer monoclonal antibodies market
Exhibit 17: Pipeline molecules for global immune checkpoint inhibitors market
Exhibit 18: Phase III pipeline molecules for global cancer vaccines market
Exhibit 19: Near-launch immuno-oncology pipeline assets
Exhibit 20: Global cancer immunotherapies market 2015-2020 ($ billions)
Exhibit 21: Factors influencing global cancer immunotherapies market
Exhibit 22: Five forces analysis
Exhibit 23: Global cancer immunotherapies market by type 2015
Exhibit 24: Timeline for approvals of cancer monoclonal antibodies by US FDA
Exhibit 25: Clinical trials of cancer monoclonal antibodies by development phase
Exhibit 26: Status of clinical trials of cancer monoclonal antibodies
Exhibit 27: Global cancer immunotherapies market by type of cancer immunotherapies 2015
Exhibit 28: Global cancer immunotherapies market by type of cancer immunotherapies 2015-2020 ($ billions)
Exhibit 29: Global cancer monoclonal antibodies market 2015-2020 ($ billions)
Exhibit 30: Key drivers and challenges of global cancer monoclonal antibodies market
Exhibit 31: Global cancer vaccines market 2015-2020 ($ billions)
Exhibit 32: Global cancer vaccines market by application 2015
Exhibit 33: Key drivers and challenges of global cancer vaccines market
Exhibit 34: Global immune checkpoint inhibitors market 2015-2020 ($ billions)
Exhibit 35: Key drivers and challenges for global immune checkpoint inhibitors market
Exhibit 36: Global non-specific immunotherapies market 2015-2020 ($ billions)
Exhibit 37: Global cancer immunotherapies market by geography 2015
Exhibit 38: Global cancer immunotherapies market revenue by geography 2015-2020 ($ billions)
Exhibit 39: Cancer immunotherapies market in Americas 2015-2020 ($ billions)
Exhibit 40: Cancer immunotherapies market in EMEA 2015-2020 ($ billions)
Exhibit 41: Cancer immunotherapies market in APAC 2015-2020 ($ billions)
Exhibit 42: Global incidence of cancer 2015 and 2020 in millions
Exhibit 43: Impact of drivers
Exhibit 44: Patent expiries of major cancer monoclonal antibodies by 2020
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Expected combination regimen launches in oncology
Exhibit 47: Top cancer immunotherapies based on sales 2014 ($ billions)
Exhibit 48: YoY Sales comparison of top drugs 2011-2014 ($ billions)
Exhibit 49: Cancer immunotherapy companies by origin country
Exhibit 50: Amgen: YoY growth and revenue generated from net product sales of Xgeva 2011-2014 ($ millions)
Exhibit 51: Amgen: YoY growth and revenue generated from net product sales of Prolia 2011-2014 ($ millions)
Exhibit 52: Amgen: YoY growth and revenue generated from net product sales of Vectibix worldwide excluding Japan 2011-2014 ($ millions)
Exhibit 53: Amgen: YoY growth and revenue of Vectibix in US 2012-2014 ($ millions)
Exhibit 54: Amgen: YoY growth and revenue of Vectibix in ROW 2012-2014 ($ millions)
Exhibit 55: Amgen: Key takeaways
Exhibit 56: Bristol-Myers Squibb: Segmentation by revenue 2014
Exhibit 57: Bristol-Myers Squibb: Revenue of oncology products by category 2014
Exhibit 58: Bristol-Myers Squibb: YoY growth and revenue generated from net product sales of Yervoy 2011-2014 ($ millions)
Exhibit 59: Bristol-Myers Squibb: YoY growth and revenue of Erbitux in US, Canada, and Japan 2010-2014 ($ millions)
Exhibit 60: Bristol-Myers Squibb: Key takeaways
Exhibit 61: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of MabThera/Rituxan 2011-2014 ($ billions)
Exhibit 62: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Avastin 2011-2014 ($ billions)
Exhibit 63: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Herceptin 2011-2014 ($ billions)
Exhibit 64: F. Hoffmann-La Roche: YoY growth and revenue of Herceptin in US 2013-2014 ($ billions)
Exhibit 65: F. Hoffmann-La Roche: YoY growth and revenue of Herceptin in EU 2013-2014 ($ billions)
Exhibit 66: F. Hoffmann-La Roche: YoY growth and revenue of Herceptin in Japan 2013-2014 ($ millions)
Exhibit 67: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Perjeta 2012-2014 ($ millions)
Exhibit 68: F. Hoffmann-La Roche: Revenue generated from net product sales of Kadcyla 2013-2014 ($ millions)
Exhibit 69: F. Hoffmann-La Roche: Key takeaways
Exhibit 70: GlaxoSmithKline: YOY growth and revenue of Arzerra 2012-2014 ($ millions)3
Exhibit 71: GlaxoSmithKline: YOY growth and revenue of Cervarix 2012-2014 ($ millions)3
Exhibit 72: GlaxoSmithKline: Key takeaways
Exhibit 73: Merck: YoY growth and revenue of Gardasil 2012-2014 ($ billions)6
Exhibit 74: Merck: YoY growth and revenue generated from net product sales of Erbitux, excluding US, Canada, and Japan 2011-2014 ($ billions
Exhibit 75: Merck: YOY growth and revenue of Erbitux in Europe 2012-2014 ($ millions)
Exhibit 76: Merck: YOY growth and revenue of Erbitux in emerging markets 2012-2014 ($ millions)
Exhibit 77: Merck: YOY growth and revenue of Erbitux in ROW 2012-2014 ($ millions)
Exhibit 78: Merck: Region-wise revenues of Erbitux 2012-2014 ($ millions)
Exhibit 79: Merck: Key takeaways
Exhibit 80: Takeda Pharmaceuticals: YoY growth and revenue generated from net product sales of Adcetris ($ millions)
Exhibit 81: Takeda Pharmaceuticals: YoY growth and revenue of Vectibix in Japan ($ millions)
Exhibit 82: Takeda Pharmaceuticals: Key takeaways
【レポート販売概要】
■ タイトル：がん免疫療法の世界市場：モノクローナル抗体、免疫チェックポイント阻害薬、がんワクチン■ 英文：Global Cancer Immunotherapies Market 2016-2020
■ 発行日：2016年4月27日
■ 調査会社：Technavio
■ 商品コード：IRTNTR8400
■ 調査対象地域：グローバル
- コーテッドファブリックの世界市場予測（～2021年）：高分子コーテッドファブリック、ゴムコーテッドファブリック、ファブリック壁装材The global coated fabrics market is projected to reach USD 24.91 Billion by 2021, at a CAGR of 4.1% from 2016 to 2021.The global coated fabrics market is driven by the increased demand from end-use applications, such as, transportation, protective clothing, industrial, furniture & seating, and roofing, awnings & canopies and others including geotextiles, packaging, sports & leisure, agriculture an …
- 世界の酪農・家畜管理市場動向と予測（～2018）The global dairy herd management market is segmented by application, end user, product, and geography. The application segments included in this report are animal comfort, calf management, feeding management, heat stress management, milk harvesting, reproduction management, and other applications. The end-user segments included in this report are dairy farms and other end users. The dairy farms se …
- 帯ひもの世界市場分析：製品別（ポリエステル、ナイロン、ポリプロピレン、炭素繊維、パラアラミド合成繊維、UHMWPE）、用途別（自動車および輸送、スポーツ用品、家具、軍用/防衛）、セグメント予測、-2020The Global Webbing Market is expected to reach USD 3.52 billion by 2020, according to a new study by Grand View Research, Inc. Webbing demand is expected to grow with widening application scope including seat belts, safety harnesses and towing straps in automotive and transportation. Increasing construction spending coupled with growth in automotive manufacturing is expected to be critical for mar …
- 嚢胞性線維症（CF）治療の世界市場分析The global cystic fibrosis therapeutics market is expected to reach USD 13.9 billion by 2025, according to a new report by Grand View Research, Inc. The rising prevalence of Cystic Fibrosis (CF) globally, research & development activities undertaken by key players, and favorable initiatives undertaken by nonprofit organizations are expected to boost the market over the forecast period. The rising …
- エチレン・酢酸ビニル（EVA）の世界市場：VLEVA、LEVA、MEVA、HEVAThe global ethylene vinyl acetate (EVA) market size, in terms of value, is projected to reach USD 9.71 Billion by 2020, at a CAGR of 3.5% between 2015 and 2020. The high potential from the packaging and footwear & foam industry, increasing global demand for EVA in solar energy sector, and continuous expansion and merger & acquisition activities undertaken by different companies are the key factors …
- 風力発電オートメーションの世界市場2016-2020About Wind Automation The use of geared motors and drives, PLC, SCADA, and DCS has increased the efficiency of wind power electricity generation. The geared motor and drive component of a windmill controls the rotational speed and directions of the turbine. PLC, SCADA, and DCS solutions help in monitoring and controlling of the turbines. The solutions are also used to store, transmit, and distribu …
- 装置産業向けフィールドバス・ソリューションの世界市場2016-2020About the Fieldbus Solution Market for Process Industry Fieldbus refers to a two-way communication digital network that uses physical data and application layers of the open systems interconnection (OSI) model. It is a control network used for process automation, which connects field devices with controller. Process industries worldwide are increasingly using Fieldbus-incorporated measurement inst …
- グローバルにおける包装機械市場（2014-2018）About Packaging Machinery Packaging machineries are the special types of machineries that provide assistance for packaging the products before its being dispatch for storage and distribution networks. Packaging is being increasingly considered an important part of marketing mix as packaging created a strong impact on the customers buying decision. Packaging machinery is widely used for filling, la …
- 炭素繊維樹脂の世界市場：熱硬化性、熱可塑性、プリプレグ、非プリプレグ、用途MarketsandMarkets projects the global carbon fiber resin market to grow from USD 292.7 Million in 2016 to USD 532.7 Million by 2021, at a compound annual growth rate (CAGR) of 12.7% during the same period. The global carbon fiber resin market witnessed a strong growth in the past few years considering the high demand for lightweight and superior mechanical properties materials, in the U.S., German …
- 皮膚科用診断装置の世界市場：顕微鏡、イムノアッセイ、分子診断About Dermatology Diagnostic Devices Market The global dermatology diagnostic devices market is dominated by microscopes with a market share of 34% owing to its convenience in use. They are used in almost every skin diagnostic procedures to identify the skin condition/ailment. Technological improvements in the field of microscopy are focused on enhancing the accuracy and sensitivity of the detecti …
- 線維肉腫：世界の臨床試験レビュー（2014年上半期）Fibrosarcoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Fibrosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Fibrosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fibrosarcoma. It includes an overview of the trial numbers and their recruitment status as per the sit …
- 世界の自動車用OE照明（ライト）市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE lighting sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE lighting market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospects Mar …
- 侵入検出システム/侵入防止システムのグローバル市場動向(2014-2019)The complete Global Intrusion Detection and Prevention System security market is categorized basically into three segments Network based, Host based and Wireless IDS/IPS solutions. The evolution of the IDS/IPS security solutions was started with the Host based solution when first time Intrusion Detection systems was designed for the military and defense purpose. Later on the other two segments eme …
- ナイトスキンケア製品の世界市場2016-2020About Night Skin Care Products Night skin care products are used to reduce symptoms of aging, acne, wrinkles, and other blemishes. These products include creams, serums, and masks with different functional properties such as skin brightening, anti-aging, and anti-wrinkle. Technavio’s analysts forecast the global skin care products market to grow at a CAGR of 4.91% during the period 2016-2020. [Cov …
- 世界のネットワーク・アプリケーション及びソフトウェア市場動向（2012-2016）TechNavio's analysts forecast the Global Network Applications and Software market to grow at a CAGR of 7.41 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapidly growing network traffic. The Global Network Applications and Software market has also been witnessing an increasing number of mergers and acquisitions. However, the security issues in …
